Effect of allopurinol on albuminuria in type 2 diabetic kidney disease with hyperuricemia

Objective To evaluate the therapeutic effect of allopurinol on albuminuria in patients with? type 2 diabetic kidney disease combined with hyperuricemia. Methods Sixty-one patients with type 2diabetic kidney disease combined with hyperuricemia were randomly divided into two groups: research group( n...

Full description

Saved in:
Bibliographic Details
Main Authors: CHEN Wen-hui, DING Guo-hua, CHEN Xing-hua, XIA Xiao-bing
Format: Article
Language:zho
Published: Editorial Department of Journal of Clinical Nephrology 2017-01-01
Series:Linchuang shenzangbing zazhi
Subjects:
Online Access:http://www.lcszb.com/thesisDetails?columnId=57918214&Fpath=home&index=0
Tags: Add Tag
No Tags, Be the first to tag this record!
_version_ 1850187095408115712
author CHEN Wen-hui
DING Guo-hua
CHEN Xing-hua
XIA Xiao-bing
author_facet CHEN Wen-hui
DING Guo-hua
CHEN Xing-hua
XIA Xiao-bing
author_sort CHEN Wen-hui
collection DOAJ
description Objective To evaluate the therapeutic effect of allopurinol on albuminuria in patients with? type 2 diabetic kidney disease combined with hyperuricemia. Methods Sixty-one patients with type 2diabetic kidney disease combined with hyperuricemia were randomly divided into two groups: research group( n = 31) and control group( n = 30). Patients in research group received routine treatment and low dose of allopurinol for 6 months,and those in control group were only treated with routine treatment. The fasting blood glucose( FBG),postprandial two-hour blood glucose( 2h PBG),hemoglobin A1c( HbA1c),serum uric acid( SUA),blood urea nitrogen( BUN),serum creatinine( SCr),triacylglycerol( TG),total cholesterol( TC),low density lipoprotein cholesterol( LDL-C),high density lipoprotein cholesterol( HDL-C),blood high-sensitivity creactive protein( hs-CRP),interleukin-6( IL-6),tumor necrosis factor-alpha( TNF-α),albumin-to-creatinine ratio( ACR),urine albumin excretion( MAU),fasting insulin( FINS) and insulin resistance index( HOMA-IR) were evaluated pre-and post-treatment. Results Before the treatment,there were no significant differences in the general information and biochemical data between the two groups( P > 0. 05). Six months later,the levels of SUA,hs-CRP,IL-6,TNF-α,MAU,ACR,FBG,FINS and HOMA-IR in the research group were significantly decreased as compared with those in the control group( P< 0. 001). Conclusions Allopurinol is an effective in the treatment of albuminuria in patients with type 2diabetes mellitus combined with hyperuricemia. It can protect renal function in early stage through controlling SUA and reducing insulin resistance to reduce urinary protein excretion.
format Article
id doaj-art-a9a844cd756d45d3989f1b3864fc8061
institution OA Journals
issn 1671-2390
language zho
publishDate 2017-01-01
publisher Editorial Department of Journal of Clinical Nephrology
record_format Article
series Linchuang shenzangbing zazhi
spelling doaj-art-a9a844cd756d45d3989f1b3864fc80612025-08-20T02:16:10ZzhoEditorial Department of Journal of Clinical NephrologyLinchuang shenzangbing zazhi1671-23902017-01-0114314757918214Effect of allopurinol on albuminuria in type 2 diabetic kidney disease with hyperuricemiaCHEN Wen-huiDING Guo-huaCHEN Xing-huaXIA Xiao-bingObjective To evaluate the therapeutic effect of allopurinol on albuminuria in patients with? type 2 diabetic kidney disease combined with hyperuricemia. Methods Sixty-one patients with type 2diabetic kidney disease combined with hyperuricemia were randomly divided into two groups: research group( n = 31) and control group( n = 30). Patients in research group received routine treatment and low dose of allopurinol for 6 months,and those in control group were only treated with routine treatment. The fasting blood glucose( FBG),postprandial two-hour blood glucose( 2h PBG),hemoglobin A1c( HbA1c),serum uric acid( SUA),blood urea nitrogen( BUN),serum creatinine( SCr),triacylglycerol( TG),total cholesterol( TC),low density lipoprotein cholesterol( LDL-C),high density lipoprotein cholesterol( HDL-C),blood high-sensitivity creactive protein( hs-CRP),interleukin-6( IL-6),tumor necrosis factor-alpha( TNF-α),albumin-to-creatinine ratio( ACR),urine albumin excretion( MAU),fasting insulin( FINS) and insulin resistance index( HOMA-IR) were evaluated pre-and post-treatment. Results Before the treatment,there were no significant differences in the general information and biochemical data between the two groups( P > 0. 05). Six months later,the levels of SUA,hs-CRP,IL-6,TNF-α,MAU,ACR,FBG,FINS and HOMA-IR in the research group were significantly decreased as compared with those in the control group( P< 0. 001). Conclusions Allopurinol is an effective in the treatment of albuminuria in patients with type 2diabetes mellitus combined with hyperuricemia. It can protect renal function in early stage through controlling SUA and reducing insulin resistance to reduce urinary protein excretion.http://www.lcszb.com/thesisDetails?columnId=57918214&Fpath=home&index=0AllopurinolHyperuricemiaDiabetic kidney diseaseAlbuminuria
spellingShingle CHEN Wen-hui
DING Guo-hua
CHEN Xing-hua
XIA Xiao-bing
Effect of allopurinol on albuminuria in type 2 diabetic kidney disease with hyperuricemia
Linchuang shenzangbing zazhi
Allopurinol
Hyperuricemia
Diabetic kidney disease
Albuminuria
title Effect of allopurinol on albuminuria in type 2 diabetic kidney disease with hyperuricemia
title_full Effect of allopurinol on albuminuria in type 2 diabetic kidney disease with hyperuricemia
title_fullStr Effect of allopurinol on albuminuria in type 2 diabetic kidney disease with hyperuricemia
title_full_unstemmed Effect of allopurinol on albuminuria in type 2 diabetic kidney disease with hyperuricemia
title_short Effect of allopurinol on albuminuria in type 2 diabetic kidney disease with hyperuricemia
title_sort effect of allopurinol on albuminuria in type 2 diabetic kidney disease with hyperuricemia
topic Allopurinol
Hyperuricemia
Diabetic kidney disease
Albuminuria
url http://www.lcszb.com/thesisDetails?columnId=57918214&Fpath=home&index=0
work_keys_str_mv AT chenwenhui effectofallopurinolonalbuminuriaintype2diabetickidneydiseasewithhyperuricemia
AT dingguohua effectofallopurinolonalbuminuriaintype2diabetickidneydiseasewithhyperuricemia
AT chenxinghua effectofallopurinolonalbuminuriaintype2diabetickidneydiseasewithhyperuricemia
AT xiaxiaobing effectofallopurinolonalbuminuriaintype2diabetickidneydiseasewithhyperuricemia